Live-Suche
TopFind ruft die neuesten Treffer für deine Suche ab.
Wir haben 8 Live-Ergebnisse für xeljanz geprüft und auf 3 Optionen eingegrenzt, die sich zuerst am meisten zum Vergleichen eignen.
Die stärksten Themen in dieser Auswahlliste sind Pharmaceutical und Extended Release Tablets.
Quelle: Pfizer (Thailand) Ltd.
Beschreibung
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
Am besten für
Once Daily dosing, Long Term maintenance und Chronic inflammation management
Bewertung
Quelle: Pfizer (Thailand) Ltd.
Beschreibung
XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA.
Am besten für
Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions und Official brand preference
Bewertung
Quelle: Pfizer Thailand
Beschreibung
Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals.
Am besten für
Patients in Thailand, Innovator drug preference, Insured medical treatments und Hospital Based pharmacy users
Bewertung
| Vergleichen | XELJANZ XR | XELJANZ | Xeljanz (Tofacitinib) |
|---|---|---|---|
| Quelle | Pfizer (Thailand) Ltd. | Pfizer (Thailand) Ltd. | Pfizer Thailand |
| Beschreibung | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | XELJANZ is a prescription medicine containing tofacitinib, a Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis. It is available as 5 mg film-coated tablets and is registered with the Thai FDA. | Xeljanz is the innovator brand of tofacitinib registered in Thailand. It is available in 5 mg film-coated tablets and 11 mg extended-release (XR) formats for the treatment of rheumatoid arthritis, psoriatic arthritis, and ulcerative colitis at major hospitals. |
| Am besten für | Once Daily dosing, Long Term maintenance und Chronic inflammation management | Rheumatoid arthritis patients, Psoriatic arthritis, Hospital prescriptions und Official brand preference | Patients in Thailand, Innovator drug preference, Insured medical treatments und Hospital Based pharmacy users |
| Aktion | |||
| Bewertung |
Wenn du mit der ausgewogensten Option starten möchtest, empfehle ich:
"XELJANZ XR von Pfizer (Thailand) Ltd.."
Ich habe dies ausgewählt, weil Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.